FEBRUARY 29, 2016

Company

Vistagen Therapeutics, Inc.

Filed

February 29, 2016

Accession Number

0001013594-16-000852

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →